DENTON BARNES: Open Payments
NPI 1891234282 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$162 in 9 payments from 9 companies in 2025. Trend: 2023 $306 · 2024 $164 · 2025 $162
Food & beverage: $162
| Company | Payments | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Geron Corporation | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $16 |
| JAZZ PHARMACEUTICALS INC. | 1 | $15 |
| Incyte Corporation | 1 | $15 |
| Celgene Corporation | 1 | $14 |
Products named: QINLOCK, KEYTRUDA, RYTELO, VENCLEXTA, Vyloy, NERLYNX, PEMAZYRE, REBLOZYL.
Industry payments across NC — which companies pay providers there.
